Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider James Garner acquired 375,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The stock was bought at an average price of A$0.08 ($0.05) per share, for a total transaction of A$30,000.00 ($19,480.52).
Percheron Therapeutics Price Performance
Percheron Therapeutics Company Profile
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
Featured Stories
- Five stocks we like better than Percheron Therapeutics
- 5 discounted opportunities for dividend growth investors
- Tesla Investors Continue to Profit From the Trump Trade
- Insider Buying Explained: What Investors Need to Know
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- How is Compound Interest Calculated?
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
